Hematology
Conference Coverage
Webinar confronts unique issues for the bleeding disorders community facing COVID-19
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
News
COVID-19: ASTCT provides interim guidelines for transplantation
The American Society for Transplantation and Cellular Therapy document focuses on patient-treatment specifics and donor issues.
FDA/CDC
FDA approves new drug for relapsed/refractory multiple myeloma
Conference Coverage
After PCI, stopping antiplatelet therapy for surgery appears safe
NATIONAL HARBOR, MD. –
News
Tumor neoantigenicity metric improves prediction of response to immunotherapy
A new scoring system can predict response to immunotherapy in patients with melanoma, lung cancer, and kidney cancer.
News
Late effects in young cancer survivors underscore importance of high-risk screening
Childhood cancer survivors have higher standardized mortality ratios than early-adolescent and young adult cancer survivors.
Latest News
Oncologists are average in terms of happiness, survey suggests
About 29% of oncologists surveyed said they were very happy at work, and 51% said they were very happy outside of work.
News
CRISPR-engineered T cells may be safe for cancer, but do they work?
All three patients who received CRISPR-engineered T cells in a phase 1 trial experienced cancer progression but minimal toxicity.
News
Global project reveals cancer’s genomic playbook
The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.
News
U.S. cancer centers embroiled in Chinese research thefts
The U.S. Federal Bureau of Investigation has been ferreting out researchers it says have acted illegally.